MedTrace Logo

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes

NCT03578835 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2018-07-06

No results posted yet for this study

Summary

Continual surveillance of both community-acquired and nosocomial bloodstream infections for specific target organisms. Analysis of comorbidities, complications, bacterial resistance patterns, bacterial genomics (e. g. via WGS and MLST typing) for the determinants of clinical outcomes. The clinical outcomes are investigated both in the short-term (up until discharge) and the long-term (six months after index blood culture by standardized questionnaire). A predictive point-of-care score is to be developed based on these data to define high-risk patient populations requiring more intensive diagnostic and/or treatment regimens.

Conditions

  • Bloodstream Infection
  • Septic Shock

Sponsors & Collaborators

  • University Hospital Freiburg

    collaborator OTHER

  • University Hospital Lübeck

    collaborator OTHER

  • University Hospital of Berlin

    collaborator OTHER

  • University of Giessen

    collaborator OTHER

  • Universitätsklinikum Köln

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578835 on ClinicalTrials.gov